Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$435M |
| 2 |
Amazon
AMZN
|
+$334M |
| 3 |
Moderna
MRNA
|
+$53.9M |
| 4 |
Linde
LIN
|
+$44.2M |
| 5 |
DTE Energy
DTE
|
+$43.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Value ETF
IWD
|
+$63.6M |
| 2 |
Comcast
CMCSA
|
+$39.7M |
| 3 |
Evergy
EVRG
|
+$38.5M |
| 4 |
Public Service Enterprise Group
PEG
|
+$38.4M |
| 5 |
Bio-Techne
TECH
|
+$30.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.37% |
| 2 | Consumer Discretionary | 10.36% |
| 3 | Financials | 7.14% |
| 4 | Industrials | 6.8% |
| 5 | Healthcare | 6.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Bunge Global
BG
$21.7B
| $7.87M | 0.09% |
100,697
+32,124
| +47% | +$2.71M |
|
202
RTX Corp
RTX
$283B
| $7.8M | 0.09% |
91,407
+197
| +0.2% | +$16.6K |
|
203
CALL
Avis
CAR
$5.18B
| $7.79M | 0.09% |
+100,000
| New | +$8.29M |
|
204
Scorpio Tankers
STNG
$3.93B
| $7.76M | 0.09% |
351,987
-48,190
| -12% | -$979K |
|
205
General Mills
GIS
$21.4B
| $7.75M | 0.09% |
+127,285
| New | +$7.87M |
|
|
RDS.B
206
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $7.73M | 0.09% |
199,000
+187,000
| +1,558% | +$7.04M |
|
207
Mueller Water Products
MWA
$3.89B
| $7.73M | 0.09% |
535,779
+230,874
| +76% | +$3.31M |
|
208
Cummins
CMI
$80.9B
| $7.66M | 0.08% |
31,403
-2,260
| -7% | -$578K |
|
209
Hershey
HSY
$37.5B
| $7.61M | 0.08% |
43,689
-94,898
| -68% | -$16M |
|
210
Targa Resources
TRGP
$64.1B
| $7.57M | 0.08% |
170,376
-510,045
| -75% | -$19.7M |
|
211
State Street Materials Select Sector SPDR ETF
XLB
$8.87B
| $7.54M | 0.08% |
183,200
-86,452
| -32% | -$3.64M |
|
|
CIM
212
Chimera Investment
CIM
$964M
| $7.54M | 0.08% |
166,819
+21,254
| +15% | +$884K |
|
213
AB InBev
BUD
$155B
| $7.5M | 0.08% |
104,123
+91,100
| +700% | +$6.64M |
|
214
Vail Resorts
MTN
$5.45B
| $7.46M | 0.08% |
23,565
+19,168
| +436% | +$6.11M |
|
215
Cannae Holdings
CNNE
$672M
| $7.45M | 0.08% |
219,647
+163,536
| +291% | +$6.1M |
|
216
State Street Health Care Select Sector SPDR ETF
XLV
$45.5B
| $7.43M | 0.08% |
59,000
+38,700
| +191% | +$4.74M |
|
217
Lam Research
LRCX
$393B
| $7.32M | 0.08% |
+112,560
| New | +$7.11M |
|
218
Lamar Advertising Co
LAMR
$15.3B
| $7.28M | 0.08% |
+69,690
| New | +$7.09M |
|
219
Valero Energy
VLO
$100B
| $7.27M | 0.08% |
93,156
-87,001
| -48% | -$6.74M |
|
|
XLNX
220
PUT
DELISTED
Xilinx Inc
XLNX
| $7.23M | 0.08% |
+50,000
| New | +$6.36M |
|
221
Fair Isaac
FICO
$25.3B
| $7.23M | 0.08% |
14,380
-3,169
| -18% | -$1.6M |
|
222
D.R. Horton
DHI
$41.5B
| $7.22M | 0.08% |
79,898
+39,909
| +100% | +$3.75M |
|
223
LPL Financial
LPLA
$28.5B
| $7.22M | 0.08% |
53,466
+32,550
| +156% | +$4.73M |
|
224
Cigna
CI
$73.3B
| $7.15M | 0.08% |
30,165
+26,212
| +663% | +$6.55M |
|
225
Truist Financial
TFC
$61.6B
| $7.14M | 0.08% |
128,572
-21,360
| -14% | -$1.25M |
|
Similar funds
Michael Gelband's Q2 2021 Portfolio in Review
As of Q2 2021, Michael Gelband held 3,092 positions worth $9.04B, up 32% from $6.86B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Michael Gelband deployed $1.88B of net new capital in Q2 2021, opening 1,032 new positions and adding to 581 existing holdings. Its largest new stake was Linde: 151,692 shares worth $43.9M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was iShares Russell 1000 Value ETF, an estimated $63.6M trimmed.
- Michael Gelband's largest Q2 2021 buy was Linde: 151,692 shares worth $43.9M.
- Michael Gelband added most to Microsoft in Q2 2021, an estimated $435M increase.
- Michael Gelband's biggest Q2 2021 reduction was iShares Russell 1000 Value ETF, cutting an estimated $63.6M.
- Michael Gelband fully exited Charles River Laboratories in Q2 2021, selling an estimated $27.9M.
- Michael Gelband's ten largest holdings make up 35% of its $9.04B portfolio in Q2 2021.
- Michael Gelband opened 1,032 new positions and closed 820 in Q2 2021.
- Michael Gelband's portfolio value rose 32% quarter-over-quarter to $9.04B.
Based on ExodusPoint Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.